Literature DB >> 24252785

Implementation of lipid screening guidelines in children by primary pediatric providers.

Damon B Dixon1, Annabel P Kornblum1, Lyn M Steffen2, Xia Zhou2, Julia Steinberger3.   

Abstract

OBJECTIVE: To assess the awareness and implementation of lipid guidelines among primary pediatric providers. STUDY
DESIGN: An online survey was administered to primary pediatric providers (n = 1488): pediatricians, family medicine/general practitioners, and advanced practitioners (nurse practitioners/physician assistants) in Minnesota. The survey was conducted over 12 weeks in 2012-2013. A multiple-choice questionnaire was used to evaluate the participants' knowledge, screening, and management attitudes regarding pediatric lipid guidelines.
RESULTS: The overall response rate was 39% (n = 548 of 1402 successful e-mails). Respondents were primarily pediatricians and family medicine practitioners (37% each), followed by general practitioners (11%) and advanced practitioners (nurse practitioners, 5.5%; physician assistants, 1.6%). Although 74% of providers reportedly believed that lipid screening and treatment would reduce future cardiovascular risk, 34% performed no screening, 50% screened selectively, and only 16% performed universal screening. Pediatricians were more likely to screen, with 30% performing universal screening and 41% performing selective screening. Among perceived barriers to screening, providers reported uneasiness addressing lipid disorders (43%), and unfamiliarity with screening guidelines (31%). The majority (83%) were uncomfortable managing lipid disorders, and 57% were opposed to the use of lipid-lowering medications in children.
CONCLUSION: These findings underscore the need to further educate providers and supply easily accessible information on the screening and treatment of childhood lipid disorders.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24252785     DOI: 10.1016/j.jpeds.2013.10.027

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

Review 1.  Cholesterol screening and statin use in children: a literature review.

Authors:  Karen King; Alan Macken; Ophelia Blake; Clodagh S O'Gorman
Journal:  Ir J Med Sci       Date:  2018-06-01       Impact factor: 1.568

2.  Reducing the burden of disease and death from familial hypercholesterolemia: a call to action.

Authors:  Joshua W Knowles; Emily C O'Brien; Karen Greendale; Katherine Wilemon; Jacques Genest; Laurence S Sperling; William A Neal; Daniel J Rader; Muin J Khoury
Journal:  Am Heart J       Date:  2014-09-16       Impact factor: 4.749

3.  Statin Use and the Risk of Type 2 Diabetes Mellitus in Children and Adolescents.

Authors:  Nina R Joyce; Justin P Zachariah; Charles B Eaton; Amal N Trivedi; Gregory A Wellenius
Journal:  Acad Pediatr       Date:  2017-02-21       Impact factor: 3.107

Review 4.  Knowns and unknowns in the care of pediatric familial hypercholesterolemia.

Authors:  Andrew C Martin; Samuel S Gidding; Albert Wiegman; Gerald F Watts
Journal:  J Lipid Res       Date:  2017-07-12       Impact factor: 5.922

Review 5.  Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?

Authors:  Sarah Jackson; Ana Creo; Seema Kumar
Journal:  Curr Atheroscler Rep       Date:  2022-04-11       Impact factor: 5.113

6.  Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.

Authors:  Michelle L Katz; Zijing Guo; Lori M Laffel
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

7.  Variation in Preventive Care in Children Receiving Chronic Glucocorticoid Therapy.

Authors:  Matthew L Basiaga; Evanette K Burrows; Michelle R Denburg; Kevin E Meyers; Andrew B Grossman; Petar Mamula; Robert W Grundmeier; Jon M Burnham
Journal:  J Pediatr       Date:  2016-09-09       Impact factor: 4.406

8.  Temporal trends in lipid screening and therapy among youth from 2002 to 2012.

Authors:  Justin P Zachariah; Catherine J McNeal; Laurel A Copeland; Ying Fang-Hollingsworth; Eileen M Stock; FangFang Sun; Joon Jin Song; Sean T Gregory; Jeffrey O Tom; Eric A Wright; Jeffrey J VanWormer; Andrea E Cassidy-Bushrow
Journal:  J Clin Lipidol       Date:  2015-07-09       Impact factor: 4.766

9.  Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years.

Authors:  Nina Joyce; Gregory A Wellenius; David D Dore; Jane W Newburger; Justin P Zachariah
Journal:  J Pediatr       Date:  2015-05-04       Impact factor: 4.406

10.  Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.

Authors:  Justin H Berger; Feiyan Chen; Jennifer A Faerber; Michael L O'Byrne; Julie A Brothers
Journal:  Am Heart J       Date:  2020-10-24       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.